Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
ESTEVE Invests US$108 mn (€100 mn) to Construct New Plant in Spain
ESTEVE plans to invest US$108 mn 100 mn to construct new plant in its industrial centre in celr girona, Spain The new facility will expand its production capacity for active pharmaceutical ingredients at its primary industrial centre
Kadans Science Partner Plans to Construct New Lab Facility in Massachusetts, USA
Kadans Science Partner plans for the construction of new purposebuilt wet lab facilities at Massachusetts, USA The 139,000 square feet development will feature six storeys of cuttingedge lab and office space, designed with full flexibility to accommodate either single or multiple tenants
Grünenthal Invests US$88 million (€80 million) to Open Production Site in Latin America
Grnenthal invests US$88 million 80 million in its Latin American production facilities to enhance the reliability of medicine supply for patients The 50,000squaremeter campus is Ecuadors largest and most advanced pharmaceutical
INCOG BioPharma Expands its Manufacturing Facilities in USA
INCOG BioPharma Services plans to expand its second building, enhanced manufacturing capabilities in USA The expansion includes the construction of a second 100,000squarefoot facility on its campus, scheduled to break ground in August
US Speciality Formulations Invests US$15 million to Expand its Biopharma Facility in USA
US Speciality Formulations USSF invests US$15 million to expand its Lehigh Valley biopharma facility in USA The expansion will introduce new clean room suites and advanced automated packaging and product inspection equipment
The University of Chicago Opens New Manufacturing Facility in USA
The University of Chicago is set to open a new manufacturing facility in the USA The new manufacturing facility is equipped for bacterial manufacturing in an anaerobic environment, supporting fermentation, lyophilisation, and encapsulation of live biotherapeutic products
BeiGene Invests US$800 million to Construct New R & D facility in China
BeiGene is investing US$800 million in constructing a new research and development RD facility in China The new facility features stateoftheart biologics manufacturing capabilities along with a clinical research and development centre
The University of Queensland plans to Open a Lab in Australia
The University of Queensland plans to open a new UQ lab to develop personalised cancer vaccines in Australia This stateoftheart lab will consolidate the necessary equipment and expertise to design,
CordenPharma Invests US$981 million (€900 mn) to Expand in USA & Europe
CordenPharma is investing US$981 million 900 million to expand its peptide platform at its sites in USA, and Europe The expansions, which encompass both enhancements to existing facilities
LOTTE Biologics Invests US$3.5 billion (₩4.6T) to Open New Bio Campus in Korea
LOTTE Biologics is investing US$35 billion 46 trillion to construct a new Bio Campus in Songdo, Incheon, Korea This stateoftheart facility, covering an impressive
